Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa.

Lesage C, Adnot-Desanlis L, Perceau G, Bonnet M, Palot JP, Bernard P, Reguiaï Z.

Eur J Dermatol. 2012 Sep-Oct;22(5):640-4. doi: 10.1684/ejd.2012.1795.

PMID:
22759562
2.

A review of wide surgical excision of hidradenitis suppurativa.

Alharbi Z, Kauczok J, Pallua N.

BMC Dermatol. 2012 Jun 26;12:9. doi: 10.1186/1471-5945-12-9. Review.

3.

Dissecting Cellulitis of the Scalp Responding to Intravenous Tumor Necrosis Factor-alpha Antagonist.

Wollina U, Gemmeke A, Koch A.

J Clin Aesthet Dermatol. 2012 Apr;5(4):36-9.

4.

A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa.

Sotiriou E, Goussi C, Lallas A, Chovarda E, Apalla Z, Lazaridou E, Ioannides D.

J Drugs Dermatol. 2012 May;11(5 Suppl):s15-20.

PMID:
22644772
5.

Long-term efficacy of infliximab in hidradenitis suppurativa.

Paradela S, Rodríguez-Lojo R, Fernández-Torres R, Arévalo P, Fonseca E.

J Dermatolog Treat. 2012 Aug;23(4):278-83. doi: 10.3109/09546634.2012.683767. Epub 2012 Jun 5.

PMID:
22482700
6.

The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review.

van Rappard DC, Limpens J, Mekkes JR.

J Dermatolog Treat. 2013 Oct;24(5):392-404. doi: 10.3109/09546634.2012.674193. Epub 2012 Apr 12. Review.

PMID:
22397574
7.

Increased prevalence of metabolic syndrome in patients with acne inversa.

Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, Philipp S, Uribe D, Wolk K, Sterry W.

PLoS One. 2012;7(2):e31810. doi: 10.1371/journal.pone.0031810. Epub 2012 Feb 16.

8.

Nicastrin mutations in French families with hidradenitis suppurativa.

Miskinyte S, Nassif A, Merabtene F, Ungeheuer MN, Join-Lambert O, Jais JP, Hovnanian A.

J Invest Dermatol. 2012 Jun;132(6):1728-30. doi: 10.1038/jid.2012.23. Epub 2012 Feb 23. No abstract available.

9.

Considering hidradenitis suppurativa as a bacterial biofilm disease.

Kathju S, Lasko LA, Stoodley P.

FEMS Immunol Med Microbiol. 2012 Jul;65(2):385-9. doi: 10.1111/j.1574-695X.2012.00946.x. Epub 2012 Mar 12.

10.

A study on the management of hidradenitis suppurativa with retinoids and surgical excision.

Puri N, Talwar A.

Indian J Dermatol. 2011 Nov;56(6):650-1. doi: 10.4103/0019-5154.91821.

11.

Depression in patients with hidradenitis suppurativa.

Onderdijk AJ, van der Zee HH, Esmann S, Lophaven S, Dufour DN, Jemec GB, Boer J.

J Eur Acad Dermatol Venereol. 2013 Apr;27(4):473-8. doi: 10.1111/j.1468-3083.2012.04468.x. Epub 2012 Feb 20.

PMID:
22339940
12.

Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature.

Girouard SD, Falk RH, Rennke HG, Merola JF.

Dermatol Online J. 2012 Jan 15;18(1):2. Review.

PMID:
22301039
13.

Clinical practice. Hidradenitis suppurativa.

Jemec GB.

N Engl J Med. 2012 Jan 12;366(2):158-64. doi: 10.1056/NEJMcp1014163. Review. No abstract available.

PMID:
22236226
14.

Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.

Van Rappard DC, Mekkes JR.

Br J Dermatol. 2012 Jul;167(1):206-8. doi: 10.1111/j.1365-2133.2012.10807.x. Epub 2012 Mar 13. No abstract available.

PMID:
22229974
15.

Squamous cell carcinoma complicating chronic suppurative hydradenitis.

Losanoff JE, Sochaki P, Khoury N, Levi E, Salwen WA, Basson MD.

Am Surg. 2011 Nov;77(11):1449-53.

PMID:
22196655
16.

A systematic review of treatments for hidradenitis suppurativa.

Rambhatla PV, Lim HW, Hamzavi I.

Arch Dermatol. 2012 Apr;148(4):439-46. doi: 10.1001/archdermatol.2011.1950. Epub 2011 Dec 19. Review.

PMID:
22184715
17.

Interstitial keratitis secondary to severe hidradenitis suppurativa responding to adalimumab.

Blanco R, González-Vela MC, González-López MA, Fernández-Llaca H, Cañal J, González-Gay MA.

Cornea. 2012 Feb;31(2):206; author reply 206. doi: 10.1097/ICO.0b013e31820ce137. No abstract available.

PMID:
22146546
18.

Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.

Emelianov VU, Bechara FG, Gläser R, Langan EA, Taungjaruwinai WM, Schröder JM, Meyer KC, Paus R.

Br J Dermatol. 2012 May;166(5):1023-34. doi: 10.1111/j.1365-2133.2011.10765.x. Epub 2012 Apr 4.

PMID:
22136668
19.

Atypical hidradenitis suppurativa involving the posterior neck and occiput.

Syed ZU, Hamzavi IH.

Arch Dermatol. 2011 Nov;147(11):1343-4. doi: 10.1001/archdermatol.2011.329. No abstract available.

PMID:
22106138
20.

Management of recalcitrant hidradenitis suppurativa with ustekinumab.

Sharon VR, Garcia MS, Bagheri S, Goodarzi H, Yang C, Ono Y, Maverakis E.

Acta Derm Venereol. 2012 May;92(3):320-1. doi: 10.2340/00015555-1229. No abstract available.

Supplemental Content

Support Center